Continue reading here:
Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods - Science
Monthly Archives: August 2022
A genetics startup wants to bring the Tasmanian tiger back from extinction – Popular Science
It looks like the thylacines (aka the Tasmanian tiger) turn to enter the debate on whether or not scientists can or should bring species back from extinction.Colossal Biosciences & Laboratories, announced yesterday that it plans to resurrect the extinct marsupial. The self-titled de-extinction company based in Dallas first made headlines last September when with its plans to de-extinct the Wooly Mammoth.
[ Related: This CRISPR startup thinks that mammoths can save the Arctic. Is it right? ]
The Tasmanian tiger was a dog-sized carnivorous marsupial with sharp claws, that was native to New Guinea, the Australian mainland, and Tasmania for four million years. Sporting yellowish to gray fur and distinctive tiger stripes covering its body, it first disappeared from the mainland about 2,000 years ago. The National Australia Museum speculates multiple factors, including over hunting and the introduction of the dingo led to this first wave of extinction.
By the late 19th and early 20th centuries, Europeans began to colonize the island of Tasmaniaan island about 150 miles south of Australia. They incorrectly blamed the marsupials for killing their chickens and sheep and thylacines were slaughtered by the thousands, with the government even offering bounties for thylacine pelts. Throw in the same fight for dominance with dingoes and the Tasmanian tiger was doomed. In 1936, the last known living Tasmanian tiger died at Beaumaris Zoo in Hobart, Tasmania.
Colossal plans to use CRISPR gene-editing technology to bring back the southern marsupial. While the Jurassic Park-esque science isnt quite here yet, the company founded by tech entrepreneur Ben Lamm and Harvard geneticist George Church, laid out a 10 step plan to re-introduce a Tasmanian tiger like animal back into the wild. They are partnering with and investing in the University of Melbournes Thylacine Integrated Genetic Restoration Research Lab (TIGRR). TIGRR is currently led by marsupial evolutionary biologist and Tasmanian tiger expert Andrew Pask and has already performed the crucial first step of sequencing most of the animals genome.
The team is comparingthe sequenced thylacine genome with the fat-tailed dunnart, a marsupial from the dasyurid family that looks more like a common mouse than a dog. This species of dunnart will provide the living cells and genetic map thats theoretically needed to theoretically create both a Tasmanian tiger genome that can create life and potentially a complete specimen.
Not everyone in the marsupial conservation community is confident that this de-extinction strategy will work. In an interview with Scientific American, Australian Museum mammal expert Kris Helgen said that the dunnart DNA and thylacine DNA are far too different from one another and separated by too many millions of years of evolution to create an animal that even resembles to Tasmanian tiger. Helgen was on the team that sequenced the thylacines mitochondrial genome in 2009.
In an interview with the Sydney Morning Herald, Jeremy Austin from the Australian Centre for Ancient DNA de-extinction fairytale science, and claimed that efforts to bring back the thylacine or the mammoth are more about media attention than the actual science. In the same interview, marsupial DNA expert Dr. Mike Westerman from La Trobe University added that he is not convinced that it can be done with our current knowledge. Where on earth would a self-sustaining population be maintained?
Colossal did not announce a timeline for this de-extinction project to be completed.
Australia is no stranger to seeing its species vanish and is currently in the midst of a major biodiversity crisis. It has seen years of severe drought, historic bushfires, record-breaking floods, and six mass bleaching events on the Great Barrier Reef. A 2022 State of the Environment report commissioned by the Australian government found or reiterated that 19 ecosystems are on the brink of collapse, that there are more non-native plant species in Australia versus native ones, and that the continent has lost more species to extinction than any other. The report underscores the need for a better framework for preserving biodiversity in the region to prevent further catastrophe.
Editors Disclosure:Matt Sechrest, the managing partner ofPopular Sciences parent company, North Equity, is an investor in Colossal. He was not involved in the assigning, writing, or editing of this story.
Originally posted here:
A genetics startup wants to bring the Tasmanian tiger back from extinction - Popular Science
Genetic variants cause different reactions to psychedelic therapy – The Well : The Well – The Well
When all else fails, some patients trying to overcome alcoholism, severe depression or anxiety, and even cluster headaches, turn to psychedelic drugs, which clinical research has shown can help treat individuals with these conditions, sometimes with dramatically positive results.
But sometimes, as with any therapy, the psychedelic treatment does not work. It just takes a patient on a long strange trip.
Now, UNC School of Medicine researchers led by Dr. Bryan Roth, the Michael Hooker Distinguished Professor of Pharmacology, report that one reason for treatment disparity could be common genetic variations in one serotonin receptor.
Dr. Bryan L. Roth
Published in the journal ACS Chemical Neuroscience, the lab research in cells shows that seven variants uniquely and differentially impact the receptors response to four psychedelic drugs psilocin, LSD, 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and mescaline.
Based on our study, we expect that patients with different genetic variations will react differently to psychedelic-assisted treatments, said Roth, who leads the NIH Psychotropic Drug Screening Program. We think physicians should consider the genetics of a patients serotonin receptors to identify which psychedelic compound is likely to be the most effective treatment in future clinical trials.
After decades of taboo regarding potential therapeutic benefit of psychotropic drugs, there has been renewed interest and research in using such compounds to treat neuropsychiatric disorders, such as major depression disorder, because the drugs stimulate serotonin receptors in the brain. These receptors bind the neurotransmitter serotonin and other similar amine-containing molecules, helping regulate peoples mood and emotions, as well as their appetite. In particular, the 5-hydroxytryptamine receptor known as 5-HT2A is responsible for mediating how a person reacts to psychedelic drugs. However, there are several naturally occurring, random genetic variations, known as single nucleotide polymorphisms, or SNPs, that can affect the function and structure of the 5-HT2A receptor.
Site of the 5-HT2A serotonin receptor.
Roth and colleagues wanted to explore how variation in this one serotonin receptor changes the activity of four psychedelic therapies.
Graduate student Gavin Schmitz and postdoctoral researchers Manish Jain and Samuel Slocum used a series of experimental assays to measure the effect that seven different SNPs had onin vitro binding and signaling of the 5-HT2A serotonin receptor when in the presence of one of the four drugs. Their results indicated that some gene variations even ones far from the exact location where the drug binds to the receptor alter the way that the receptor interacts with the psychedelic drugs.
For example, the SNP Ala230Th had decreased response to one of the four drugs (psilocin the active metabolite of psilocybin) while the Ala447Val mutation showed only reduced effects to two of the drugs.
This is another piece of the puzzle we must know when deciding to prescribe any therapeutic with such dramatic effect aside from the therapeutic effect, Roth said. Further research will help us continue to find the best ways to help individual patients.
The National Institutes of Health and the Defense Advanced Research Projects Agency (DARPA) funded this research.
Read more here:
Genetic variants cause different reactions to psychedelic therapy - The Well : The Well - The Well
Some types of itches are genetic related: Expert – Telangana Today
Published: Published Date - 07:05 PM, Mon - 22 August 22
Hyderabad: Severe itching is usually associated with allergies, immunity disorders, parasitic insects and even fungal infections. However, there are instances wherein severe itching is also linked to genetics.
Sometimes, itching could be a condition that has been passed down from parents to children and in some cases it could congenital in nature.
Such rare forms of itching and links to genetics were showcased by Prof. Geoff Woods, human geneticist from Cambridge Institute for Medical Research, UK, while delivering a talk on With ExtremePhenotypes, think of Genetics, even with Itch, organised by Hyderabad-based Genome Foundation.
Dr Woods explained how genetics of a few rare diseases lead to the deciphering biological pathways. He also presented case-studies of ultra-rare diseases like congenital itch inherited in families. The geneticist in his presentation said that itch from birth in both males and females could be severe and unrelenting.
Senior officerbears from Genome Foundation including its Chairman, Dr. KPC Gandhi, Dean (Research), Prof.V.R.Rao, Director, Aparna Kaja and senior dermatologist, Dr V Anand Kumar were present.
View original post here:
Some types of itches are genetic related: Expert - Telangana Today
Before Serena Williams Shock Defeat, Floyd Mayweather Made Genetics Revelation That Likened Him to Tennis Legend – EssentiallySports
Floyd Mayweather and Serena Williams are both icons in their respective sports. It can be argued that the pair are the greatest athletes of their generation, if not the best ever. Mayweather walked away from the sport with a perfect record of 50-0 while Williams has 23-Grand Slam titles under her belt.
ADVERTISEMENT
Article continues below this ad
Moreover, Money certainly thought that he and Williams were similar in many aspects. Back in 2015, before his fight against Andre Berto, Mayweather came out in support of the tennis ace. Williams was also set to face off Roberta Vinci in the US Open Semifinals. This was an important match for her as she was on her way to becoming the first player since 1998 to hold all four major titles in a single year.
ADVERTISEMENT
Article continues below this ad
In an interview leading up to his fight, Mayweather admitted he wanted to see Williams break this record and supported her endeavors, They say records are made to be broken.
Im just very proud of her and what shes done during her career. Shes done some amazing things in her career. Its just marvelous what she did. Im behind her 100% He said
Moreover he claimed that he and Williams shared similar genetics and had an undeterred dedication to their craft. Genetics. I think that the older you get, the harder you have to work, Thats what Ive done. The older I get, the harder I work. He added.
DIVE DEEPER
Billionaire Floyd Mayweather, Known for Flaunting Millions in Cash, Once GotHilariously Trolled by Former Rival: You Think He Knows How to Write a Check?
12 days ago
Mayweather would go on to beat Berto to secure his 49th win in the sport. However, things would not turn out great for Williams as she lost to Vinic in one of tenniss biggest upsets.
Retiring with a perfect record is a feat that has only been managed by a few greats. Mayweather is one of those greats. The time and effort Money has put into becoming one of the best is unmatched. Unlike several other top boxers, he relies on his defensive prowess, using his footwork and head movement to frustrate his opponents into making mistakes.
ADVERTISEMENT
Article continues below this ad
His skills can be attributed to the countless hours he had to put in the training, especially as he got older.
Mayweather has described his mantra as hard work and dedication which has evolved into a crowd chant. He gets the crowd involved by having them say half of it and he says the other half.
ADVERTISEMENT
Article continues below this ad
Do you think Mayweather and Williams are alike? Let us know in the comments.
Watch This Story:Hardest Shots Landed on Floyd Mayweather
AgriGold to debut 15 Corn Hybrids and 35 Soybean Varieties for 2023 – Farm Progress
AgriGold will bring 15 new corn hybrids with 21 new trait additions on new and proven hybrids as well as 35 new soybean varieties to the market in 2023. Its latest soybean lineup features 14 new XtendFlexproducts, 13 new Enlist E3soybeans and a new conventional line of eight agronomically sound and versatile varieties.
One of those exciting new traits is SmartStaxPRO, which is geared toward fighting corn rootworm. It utilizes RNAi technology, providing a third mode of action against corn rootworm and tripling root node protection compared with Qromeproducts.
We take pride in selling versatile products that offer consistent results and allow farmers solutions for their unique challenges, says Whitney Monin, AgriGold national agronomy manager. The 2023 additions expand AgriGolds diverse portfolio to 80 proven corn hybrids and 74 soybean varieties, better enabling us to meet farmers needs. Thats powerful.
Related: Farm Progress America, August 23, 2022
AgriGold Field GXsimplifies decisionsAgriGolds standout hybrid categories combine world-class genetics with farmer fields.AgriGolds Field GXclassifies every hybrid into five genetic families based on genetic background and agronomic characteristics. Knowing a hybrids genetic family helps simplify management, reduce risk, and maximize results in farmers fields.
Standout new corn hybridsThe new lineup of corn hybrids aligns with AgriGolds mission of moving genetics forward, says John Brien, AgriGold eastern agronomy manager. He details, The 2023 offerings with relative maturities (RM) ranging from 89 to 120 days averaged an impressive 5.8 bushel per acre genetic gain compared with last years lineup.
Just a few of the hybrids expected to make waves in 2023 include the following:
Related: Country star, equipment company enter new collaboration
The hybrid profile is an important component of AgriGolds story. To better relay that story to the farmer, the seed company has improved its ear flex categorization. It now categorizes products based on ear length, ear girth and kernel flex, telling a more complete story that farmers can leverage.
This is the biggest change weve made in years, and its a shift aimed at telling farmers a lot more about the hybrids they are purchasing and how they fit their ground, management style and goals, Brien explains.
Soybean offerings expandOur soybean portfolio is bigger and more diverse than it has ever been before, Western Agronomy Manager Steve Schany says, referencing the companys 74 different soybean varieties with maturities spanning from 0.3 to a 6.4 determinant soybean. Our 2023 soybean platform is the most offensive we have offered to date, he says, adding Weve been able to maintain an outstanding 2.44 bushel per acre annual genetic gain in this new launch class.
The following are some standouts from the class of 2023:
AgriGold will also simplify its seed treatment options with the 2023 lineup to ensure adequate supplies while still providing the flexibility for farmers to select a value or premium option. Schany explains, Weve upgraded two major ingredients in our AgriShieldMAX with Saltroseed treatment. We have replaced metalaxyl with a mefenoxam for improvedPythiumcontrol. Were also stepping upRhizoctoniacontrol with the addition of the brand new, industry-leading sedaxane.
Robust AgriGold lineup gives farmers more freedom to chooseAgriGolds large and diverse portfolio of corn and soybean products deliver freedom. Our farmer customers have the freedom to choose the trait thats best for their farm, their management style and their yield goals thanks to our robust product offerings, Monin says.
Source: AgriGold,who is solely responsible for the information provided and is wholly owned by the source. Informa Business Media and all itssubsidiaries are not responsible for any of the content contained in this information asset.
Continue reading here:
AgriGold to debut 15 Corn Hybrids and 35 Soybean Varieties for 2023 - Farm Progress
Genetics and management drive lamb weights to record level – Sheep Central
NATIONAL lamb carcase weights reached record highs in the last financial year, the release of Australian Bureau of Statistics data has revealed.
Meat & Livestock Australias market information manager Stephen Bignell said lamb slaughter for Q2 in FY2022 was recorded at 5.44 million, an increase of 9.5 percent on the previous quarter and 1.1pc higher than the June 2021 quarter.
For the full financial year, lamb slaughter nationally stood at 20.8m lambs.
The fact that lamb slaughter for Q2 2022 (October to December 2021) was not within in the historical top 20 lamb slaughter volumes, but was the third highest level of production, shows the benefits of increasing carcase weights, he said.
The implementation of new genetics, well managed on-farm production and above average rainfall patterns have ensured national lamb carcase weights achieved record highs in Q2 2022.
At 25.8kg/head, this was a 0.6pc increase year-on-year levels, demonstrating that genetic improvement and management is driving increased efficiencies and production for the national lamb flock, Mr Bignell said.
New South Wales lambs weighed 26.8kg/head on average, leading the trend for heavier lambs nationally, followed by South Australian lambs at 26.7kg/head.
The value of lambs and sheep slaughtered in FY2022 was $5.13 billion, 14.5pc above the value of sheep and lambs slaughtered in FY2021.
The second quarter in FY2022 (October to December 2021) recorded the highest value of sheep and slaughtered ever, MLA said. The average price for a finished lamb/sheep in FY22 was $189.39, up 10.5pc on 2021.
In Q2 of 2022, lamb production was 140,165 tonnes, the third highest quarterly volume on record, behind Q2 2018 and Q4 2016. The quarterly total of 140,165 tonnes was a 12.5pc increase on Q1 2022 levels and 1.8pc higher than the same quarter in 2021, MLA said.
MLA said unlike lambs and cattle, sheep slaughter fell in Q2 2022, reducing by 13.2pc or 209,600 head. However, according to Mr Bignell, a drop in slaughter in the June quarter is common as producers are retaining ewes for lambing during this period.
Encouragingly, when compared to the corresponding June period in 2021, mutton slaughter is up 27pc or close to 300,000 head.
This would suggest the flock rebuild is maturing and in line with MLAs most recent June sheep projections, he said.
MLA said production of mutton was recorded at 35,091 tonnes in Q2 2022, a 11.3pc reduction on the previous quarter, but 25pc higher than 2021 levels. As mutton production fell by less than the fall in slaughter, carcase weights climbed, MLA said.
National sheep carcase weights for Q2 2022 were recorded at 25.5kg/head, a 500g increase on Q1 2022 levels, but well below the 2.2kg/head below the highs recorded in December 2021.
Interestingly, the average carcase weights for sheep are below that of lambs on a national level.
Sheep in New South Wales are the heaviest weighting 27.3kg, while sheep in Tasmania are the lightest weighing 19.5kg/head, Mr Bignell said.
Source: MLA.
Read more:
Genetics and management drive lamb weights to record level - Sheep Central
My Genetics 330 Pounds GOAT Ronnie Coleman Once Revealed Secret to Inhuman 0.3 Fat Percentage to Joe Rogan That Helped Him Collect More Mr. Olympia…
Joe Rogan, the veteran UFC color commentator, and eight-time Mr. Olympia Ronnie Coleman, are two of the most prominent names in their respective fields. Interestingly, the duo once came together for over an hour-long chat in 2020 on the famous Joe Rogan Experience podcast hosted by the UFC color commentator.
ADVERTISEMENT
Article continues below this ad
During the episode, the duo thoroughly talked about Colemans life, including his records, diet, injuries, and more. At one point during the conversation, Rogan asked the former IFBB professional about his body fat percentage while he was competing.
ADVERTISEMENT
Article continues below this ad
The bodybuilding legend told the JRE host he had a 0.33 percent at that time, which quite stunned the latter. I was point three, three, Coleman said. Point three, three, what does that mean? Is that less than three percent? Rogan replied in shock.
Thats less than half a percent, the former Mr. Olympia further admitted. At this point, the MMA enthusiast was in disbelief. So he further asked, Point three, three like what!! How does a human get that low?
I got to attribute to my genetics, Coleman replied. Further on, Rogan asked about his offseason body fat number. About three percent, Coleman answered. The veteran UFC color commentator is a fitness enthusiast and maintains good shape by working out regularly. Thus, he has enough knowledge about bodybuilding. However, he was still shocked by Colemans statement.
So he further asked, Three was that high? To which the 8-time consecutive winner of Mr. Olympia replied, Thats the highest I am 330 pounds at that, though.
Professional bodybuilders are famous for having a very less body fat percentage. They cut down even more fat before their competition by cutting down water, sugar, fatty foods, salt, and more.
Coleman claimed about having 0.33 percent body fat during competition. His assertions, however, were refuted by physical medicine and rehabilitation specialist Dr. Brian Sutterer, who said it was inhumanely impossible.
ADVERTISEMENT
Article continues below this ad
DIVE DEEPER
Rare Photo Shows Jacked Joe Rogan Next to 300 Lbs Ronnie Coleman, Who Won MoreMr. Olympia Titles Than Arnold Schwarzenegger
3 days ago
In a YouTube video, Dr. Sutterer said it is necessary to maintain three to five percent of body fat, as fats are vital to absorb vitamins, regulate hormones, and regulate body temperature.
However, Dr. Sutterer further added that the machines that are used to measure body fat percentage arent 100 percent accurate. This might have been the case with the legendary bodybuilder, as per Dr. Sutterer.
ADVERTISEMENT
Article continues below this ad
What are your thoughts on Dr. Sutterers explanations? What do you guys think about Colemans statement on Rogans podcast? Let us know in the comments section below.
WATCH THIS STORY: 5 Best Joe Rogan Memes Following Leon Edwards Brutal Knockout Victory Over Kamaru Usman at UFC 278
Read more from the original source:
My Genetics 330 Pounds GOAT Ronnie Coleman Once Revealed Secret to Inhuman 0.3 Fat Percentage to Joe Rogan That Helped Him Collect More Mr. Olympia...
Fulgent Genetics’s Return On Invested Capital Insights – Benzinga
Pulled from Benzinga Pro data, Fulgent Genetics FLGT posted Q2 earnings of $11.10 million, an increase from Q1 of 92.77%. Sales dropped to $125.34 million, a 60.86% decrease between quarters. Fulgent Genetics earned $153.56 million, and sales totaled $320.27 million in Q1.
Earnings data without context is not clear and can difficult to base trading decisions on. Return on Invested Capital (ROIC) helps to filter signal from noise by measuring yearly pre-tax profit relative to invested capital by a business. Generally, a higher ROIC suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q2, Fulgent Genetics posted an ROIC of 1.18%.
It is important to keep in mind that ROIC evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but does not account for factors that could affect earnings and sales in the near future.
ROIC is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROIC shows Fulgent Genetics is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of invested capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.
For Fulgent Genetics, the positive return on invested capital ratio of 1.18% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.
Fulgent Genetics reported Q2 earnings per share at $0.78/share, which beat analyst predictions of $0.73/share.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Follow this link:
Fulgent Genetics's Return On Invested Capital Insights - Benzinga
The anatomy of ancient Greece – Business Standard
The book is a rewarding read even for people from non-occidental backgrounds
Topics BOOK REVIEW
The Invention of Medicine: From Homer to Hippocrates
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.
249
Select
1799
Select
Best Offer
1799
Select
150 /for 5 articles
VIEW ALL FAQs
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
First Published: Wed, August 24 2022. 00:53 IST
Read the original:
The anatomy of ancient Greece - Business Standard